Metrics as of 10/16/2026, 06:18 AM (Berlin time), refresh in progress.
Doximity, Inc.
Doximity, Inc. is a healthcare company operating within the Medical - Healthcare Information Services industry. The company provides a cloud-hosted digital platform specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools that empower its…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
1D
+5.3%
1W
+7.2%
1M
+22.0%
6M
+29.9%
YTD
-28.9%
1Y
-53.7%
2Y
-28.2%
5Y
-54.9%
10Y
–
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~164% stronger price swings than usual
PRICE TARGET LOW
US$18.00
CONSENSUS
US$27.00
MEDIAN
US$25.50
PRICE TARGET HIGH
US$41.00
1
STRONG BUY
8
BUY
13
HOLD
2
SELL
0
STRONG SELL
24
TOTAL · Hold
As of: 29/09/2026
P/E
35.39
P/B
6.28
EV/EBITDA
22.1
RETURN ON EQUITY
2.7%
NET MARGIN
15.5%
DEBT/EQUITY
0.01
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
97.0%
FLOAT SHARES
172,840,318
AVG. DAILY VOLUME (30D)
3,075,675
Sitaram Siddharth
Sitaram Siddharth
Wampler Kira Scherer
Wampler Kira Scherer
Yang Watkin Phoebe L.
1 mention today in US forums, about the same as yesterdayPrice since yesterday: +5.3%
Forums (Reddit)
Doximity, Inc. is a company in the Healthcare sector, Medical - Healthcare Information Services industry, headquartered in United States.
The CEO is Jeffrey A. Tangney, the company employs around 880 people.
The IPO was on 24/06/2021; the stock trades on NYSE under the ticker DOCS.
24 analysts rate the stock, the consensus is Hold (as of 29/09/2026).
The average price target is US$27.00, ranging from US$18.00 to US$41.00, with a median of US$25.50.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 164% stronger than usual.
No, Doximity currently does not pay a dividend.
Comparable stocks include Hinge Health, HealthEquity, Heartflow, Omada Health, Teladoc Health, Evolent Health, SOPHiA GENETICS and Optima Health.
Clicking "Analyze stock" lets five strategies assess Doximity against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.